Krill Oil-Incorporated Liposomes As An Effective Nanovehicle To Ameliorate The Inflammatory Responses Of DSS-Induced Colitis

References

• Cohen LJ, Cho JH, Gevers D, Chu H. Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases. Gastroenterology. 2019;156(8):2174–2189. doi:10.1053/j.gastro.2019.03.01730880022
   PubMed Web of Science ®Google Scholar
• Torres J, Danese S, Colombel JF. New therapeutic avenues in ulcerative colitis: thinking out of the box. Gut. 2013;62(11):1642–1652. doi:10.1136/gutjnl-2012-30395924104885
   PubMedGoogle Scholar
• Salim SY, Soderholm JD. Importance of disrupted intestinal barrier in inflammatory bowel diseases. Inflamm Bowel Dis. 2011;17(1):362–381. doi:10.1002/ibd.2140320725949
   PubMed Web of Science ®Google Scholar
• Stremmel W, Ehehalt R, Staffer S, et al. Mucosal protection by phosphatidylcholine. Dig Dis. 2012;30(Suppl 3):85–91. doi:10.1159/000342729
   PubMed Web of Science ®Google Scholar
• Karner M, Kocjan A, Stein J, et al. First multicenter study of modified release phosphatidylcholine “LT-02” in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses. Am J Gastroenterol. 2014;109(7):1041–1051. doi:10.1038/ajg.2014.10424796768
   PubMedGoogle Scholar
• Calder PC. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta. 2015;1851(4):469–484. doi:10.1016/j.bbalip.2014.08.01025149823
   PubMed Web of Science ®Google Scholar
• Costanzo M, Cesi V, Prete E, et al. Krill oil reduces intestinal inflammation by improving epithelial integrity and impairing adherent-invasive Escherichia coli pathogenicity. Dig Liver Dis. 2016;48(1):34–42. doi:10.1016/j.dld.2015.09.01226493628
   PubMedGoogle Scholar
• Grimstad T, Bjorndal B, Cacabelos D, et al. Dietary supplementation of krill oil attenuates inflammation and oxidative stress in experimental ulcerative colitis in rats. Scand J Gastroenterol. 2012;47(1):49–58. doi:10.3109/00365521.2011.63402522126533
   PubMed Web of Science ®Google Scholar
• Wang Q, Lv S, Lu J, Jiang S, Lin L. Characterization, stability, and in vitro release evaluation of carboxymethyl chitosan coated liposomes containing fish oil. J Food Sci. 2015;80(7):C1460–C1467. doi:10.1111/1750-3841.1292926077623
   PubMed Web of Science ®Google Scholar
• Beloqui A, Coco R, Alhouayek M, et al. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis. Int J Pharm. 2013;454(2):775–783. doi:10.1016/j.ijpharm.2013.05.01723694806
   PubMedGoogle Scholar
• Collnot EM, Ali H, Lehr CM. Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J Control Release. 2012;161(2):235–246. doi:10.1016/j.jconrel.2012.01.02822306429
   PubMed Web of Science ®Google Scholar
• Choi YH, Han HK. Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics. J Pharm Investig. 2018;48(1):43–60. doi:10.1007/s40005-017-0370-4
   PubMedGoogle Scholar
• Leekumjorn S, Cho HJ, Wu Y, Wright NT, Sum AK, Chan C. The role of fatty acid unsaturation in minimizing biophysical changes on the structure and local effects of bilayer membranes. Biochim Biophys Acta. 2009;1788(7):1508–1516. doi:10.1016/j.bbamem.2009.04.00219371719
   PubMedGoogle Scholar
• Notman R, Noro MG, Anwar J. Interaction of oleic acid with dipalmitoylphosphatidylcholine (DPPC) bilayers simulated by molecular dynamics. J Phys Chem B. 2007;111(44):12748–12755. doi:10.1021/jp072356417939702
   PubMed Web of Science ®Google Scholar
• Jang E-J, Choi WR, Kim S-Y, et al. 2-Hydroxyoleic acid-inserted liposomes as a multifunctional carrier of anticancer drugs. Drug Deliv. 2017;24(1):1587–1597. doi:10.1080/10717544.2017.138845229029595
   PubMed Web of Science ®Google Scholar
• Arouri A, Lauritsen KE, Nielsen HL, Mouritsen OG. Effect of fatty acids on the permeability barrier of model and biological membranes. Chem Phys Lipids. 2016;200:139–146. doi:10.1016/j.chemphyslip.2016.10.00127725161
   PubMedGoogle Scholar
• Ehringer W, Belcher D, Wassall SR, Stillwell W. A comparison of the effects of linolenic (18:3 omega 3) and docosahexaenoic (22:6 omega 3) acids on phospholipid bilayers. Chem Phys Lipids. 1990;54(2):79–88.2142021
   PubMed Web of Science ®Google Scholar
• Hong SS, Kim SH, Lim SJ. Effects of triglycerides on the hydrophobic drug loading capacity of saturated phosphatidylcholine-based liposomes. Int J Pharm. 2015;483(1–2):142–150. doi:10.1016/j.ijpharm.2015.02.01325667981
   PubMedGoogle Scholar
• Tapal A, Tiku PK. Complexation of curcumin with soy protein isolate and its implications on solubility and stability of curcumin. Food Chem. 2012;130(4):960–965. doi:10.1016/j.foodchem.2011.08.025
   Web of Science ®Google Scholar
• Jung IW, Han HK. Effective mucoadhesive liposomal delivery system for risedronate: preparation and in vitro/in vivo characterization. Int J Nanomedicine. 2014;9:2299–2306. doi:10.2147/IJN.S6118124872692
   PubMedGoogle Scholar
• Sciscione F, Pucci C, La Mesa C. Binding of a protein or a small polyelectrolyte onto synthetic vesicles. Langmuir. 2014;30(10):2810–2819. doi:10.1021/la500199w24564353
   PubMedGoogle Scholar
• Toropainen T, Velaga S, Heikkila T, et al. Preparation of budesonide/gamma-cyclodextrin complexes in supercritical fluids with a novel SEDS method. J Pharm Sci. 2006;95(10):2235–2245. doi:10.1002/jps.2070216883551
   PubMedGoogle Scholar
• Dieleman LA, Palmen MJ, Akol H, et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol. 1998;114(3):385–391. doi:10.1046/j.1365-2249.1998.00728.x9844047
   PubMed Web of Science ®Google Scholar
• Sade A, Banerjee S, Severcan F. Concentration-dependent differing actions of the nonsteroidal anti-inflammatory drug, celecoxib, in distearoyl phosphatidylcholine multilamellar vesicles. J Liposome Res. 2010;20(2):168–177. doi:10.3109/0898210090324449219848445
   PubMed Web of Science ®Google Scholar
• Serro AP, Galante R, Kozica A, et al. Effect of tetracaine on DMPC and DMPC+cholesterol biomembrane models: liposomes and monolayers. Colloids Surf B Biointerfaces. 2014;116:63–71. doi:10.1016/j.colsurfb.2013.12.04224448175
   PubMed Web of Science ®Google Scholar
• Wu Q, Uluata S, Cui L, et al. Physical and oxidation stability of self-emulsifying krill oil-in-water emulsions. Food Funct. 2016;7(8):3590–3598. doi:10.1039/c6fo00045b27443794
   PubMed Web of Science ®Google Scholar
• Minekus M, Alminger M, Alvito P, et al. A standardised static in vitro digestion method suitable for food - an international consensus. Food Funct. 2014;5(6):1113–1124. doi:10.1039/c3fo60702j24803111
   PubMed Web of Science ®Google Scholar
• Kim SY, Lee SJ, Kim JK, Choi HG, Lim SJ. Optimization and physicochemical characterization of a cationic lipid-phosphatidylcholine mixed emulsion formulated as a highly efficient vehicle that facilitates adenoviral gene transfer. Int J Nanomedicine. 2017;12:7323–7335. doi:10.2147/IJN.S14678529070949
   PubMedGoogle Scholar
• Kwon SH, Seo EB, Lee SH, et al. T cell-specific knockout of STAT3 ameliorates dextran sulfate sodium-induced colitis by reducing the inflammatory response. Immune Netw. 2018;18(4):e30. doi:10.4110/in.2018.18.e3030181918
   PubMedGoogle Scholar
• Yang JY, Kim MS, Kim E, et al. Enteric viruses ameliorate gut inflammation via toll-like receptor 3 and toll-like receptor 7-mediated interferon-beta production. Immunity. 2016;44(4):889–900. doi:10.1016/j.immuni.2016.03.00927084119
   PubMedGoogle Scholar
• Gardiner KR, Halliday MI, Barclay GR, et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut. 1995;36(6):897–901. doi:10.1136/gut.36.6.8977615280
   PubMedGoogle Scholar
• Ibarguren M, Lopez DJ, Escriba PV. The effect of natural and synthetic fatty acids on membrane structure, microdomain organization, cellular functions and human health. Biochim Biophys Acta. 2014;1838(6):1518–1528. doi:10.1016/j.bbamem.2013.12.02124388951
   PubMed Web of Science ®Google Scholar
• Arouri A, Mouritsen OG. Membrane-perturbing effect of fatty acids and lysolipids. Prog Lipid Res. 2013;52(1):130–140. doi:10.1016/j.plipres.2012.09.00223117036
   PubMedGoogle Scholar
• Mouritsen OG. Lipids, curvature, and nano-medicine. Eur J Lipid Sci Technol. 2011;113(10):1174–1187. doi:10.1002/ejlt.20110005022164124
   PubMed Web of Science ®Google Scholar
• Onuki Y, Morishita M, Chiba Y, Tokiwa S, Takayama K. Docosahexaenoic acid and eicosapentaenoic acid induce changes in the physical properties of a lipid bilayer model membrane. Chem Pharm Bull (Tokyo). 2006;54(1):68–71. doi:10.1248/cpb.54.6816394552
   PubMedGoogle Scholar
• Malinin VS, Frederik P, Lentz BR. Osmotic and curvature stress affect PEG-induced fusion of lipid vesicles but not mixing of their lipids. Biophys J. 2002;82(4):2090–2100. doi:10.1016/S0006-3495(02)75556-211916865
   PubMedGoogle Scholar
• Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in inflammation. Signal Transduct Target Ther. 2017;2. doi:10.1038/sigtrans.2017.23
   Web of Science ®Google Scholar
• Coskun M. Intestinal epithelium in inflammatory bowel disease. Front Med (Lausanne). 2014;1:24.25593900
   PubMedGoogle Scholar
• Naeem M, Choi M, Cao J, et al. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy. Drug Des Devel Ther. 2015;9:3789–3799. doi:10.2147/DDDT.S88672
   PubMed Web of Science ®Google Scholar
• Ocon B, Aranda CJ, Gamez-Belmonte R, et al. The glucocorticoid budesonide has protective and deleterious effects in experimental colitis in mice. Biochem Pharmacol. 2016;116:73–88. doi:10.1016/j.bcp.2016.07.01027431777
   PubMedGoogle Scholar
• Fukui H. Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation? Inflamm Intest Dis. 2016;1(3):135–145. doi:10.1159/00044725229922669
   PubMedGoogle Scholar
• Patole VC, Pandit AP. Mesalamine-loaded alginate microspheres filled in enteric coated HPMC capsules for local treatment of ulcerative colitis: in vitro and in vivo characterization. J Pharm Investig. 2018;48(3):257–267. doi:10.1007/s40005-017-0304-1
   Google Scholar